InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 09/18/2020 4:15:28 PM

Friday, September 18, 2020 4:15:28 PM

Post# of 43722
News; $CVM CEL-SCI Awarded European Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis

LEAPS Platform Technology being developed as a therapeutic vaccine for rheumatoid arthritis with support of a NIAMS grant of the NIH CEL-SCI Corporation (NYSE American: CVM) today announced that the European Patent Office has issued CEL-SCI patent: European Patent 2989121 to be pub...

Find out more CVM - CEL-SCI Awarded European Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News